Completed NA INTERVENTIONAL 1-arm NCT03591081

Induce (Intellin Diabetic Foot) Feasibility Study

A Feasibility Study to Explore the Implementation and Acceptance of INTELLIN, a Novel mHealth Application on the Management of People With Diabetes Who Have Recently Healed Foot Ulceration.

Sponsor: Gendius Ltd

Conditions Healed Ulcer

Interventions Intellin smart phone application

Updated 8 times since 2018 Last updated: Aug 19, 2020 Started: Jun 22, 2018 Primary completion: Mar 20, 2020 Completion: Mar 20, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Healed Ulcer and is currently completed. Gendius Ltd leads this study, which shows 8 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jun 2022 — Jul 2024 [monthly]

Completed NA
Mar 2022 — Jun 2022 [monthly]

Completed NA
Jan 2021 — Mar 2022 [monthly]

Completed NA

▶ Show 3 earlier versions

Sep 2020 — Jan 2021 [monthly]

Completed NA

Status: Enrolling By Invitation → Completed
Mar 2020 — Sep 2020 [monthly]

Enrolling By Invitation NA
Aug 2018 — Mar 2020 [monthly]

Enrolling By Invitation NA

First recorded

Jun 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Gendius Ltd
Innovate UK
Natalie Garratt

Data source: Northern Care Alliance NHS Foundation Trust

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Salford, United Kingdom